For the first time in Spain it has been used to treat non-melanoma skin cancer a therapy based on a resin with a radiopharmaceuticalwith few adverse effects and high response rates. The new treatment has been carried out at the 12 de Octubre Hospital and is a therapeutic alternative for patients with certain characteristics: they are not candidates for conventional treatments and would have a less effective result.
It is performed on an outpatient basis and does not require anesthesiaso it is very useful for this profile of patients, mostly elderly.
A thin layer of resin marked with the radiopharmaceutical is applied Rhenium-188which acts upon contact with the injury. Each patient receives the radioactive dose calculated in a personalized way. Is painless and is administered in a single session with the help of a brush-like applicator on a transparent dressing that covers the lesion to be treated, always under radiological protection measures.
The patient only has to wait for the time calculated for their personalized treatment to elapse – usually between 30 and 180 minutes on average – and, after that, he is discharged only with hydration care and sun protection for the injury.
The treatment was applied for the first time in June of this year to two patients that, after three months of follow-up, They have responded excellently.. To date there is no evidence of disease. Furthermore, patients have not experienced toxicities derived from it and have presented a very good aesthetic result.
Regarding improvements and benefits, the new technique consumes fewer hospital resources, has few adverse effects and high efficacy rates. Furthermore, recent studies show minimal relapse rates, making it a technique with similar or even superior effectiveness to surgerywhich is the standard treatment.
Those in charge of administering the treatment are the professionals of the health service. Nuclear Medicine of this Hospital, in close collaboration with the Dermatologywhich assumes the selection of candidate patients and treatment planning.
The incorporation of this treatment has its origins in the experience accumulated by doctors Diana Vega and Elisa Martínez, from the Nuclear Medicine Service of 12 de Octubre. Both specialists evaluated the effectiveness of the response to this therapy, the aesthetic results and the toxicity in 47 patients treated in the Sant’ Orsolla-Malpighi Hospitalwhere they did their MIR rotations.
These results were presented at the National Congress of the Spanish Society of Nuclear Medicine and Molecular Imaging in 2022. On October 12, this technique is now incorporated for a chosen group of candidate patients, in whom a priori a high success rate could be achieved.
#patients #October #free #skin #cancer #pioneering #therapy #Spain
